PWMG
RNAM

Private Wealth Management Group’s Avidity Biosciences RNAM Stock Holding History

Private Wealth Management Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$7.21K – 1532
2025
Q4 		$7.21K Sell
100
-21
-17% -$1.36K ﹤0.01% 627
2025
Q3 		$5.27K Sell
121
-1
-0.8% -$40 ﹤0.01% 773
2025
Q2 		$3.46K Buy
122
+34
+39% +$1.01K ﹤0.01% 906
2025
Q1 		$2.6K Buy
88
+17
+24% +$529 ﹤0.01% 970
2024
Q4 		$2.06K Sell
71
-7
-9% -$293 ﹤0.01% 1067
2024
Q3 		$3.58K Hold
78
– – ﹤0.01% 858
2024
Q2 		$3.19K Hold
78
– – ﹤0.01% 889
2024
Q1 		$1.99K Hold
78
– – ﹤0.01% 971
2023
Q4 		$706 Buy
+78
New +$521 ﹤0.01% 1380

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Private Wealth Management Group's RNAM Position: Q1 2026 in Review

Private Wealth Management Group sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 100 shares — an estimated $7.21K sold.

Private Wealth Management Group first reported a position in RNAM in Q4 2023 and held it in 9 quarters. The position peaked at $7.21K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Private Wealth Management Group reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Private Wealth Management Group sold 100 Avidity Biosciences shares in Q1 2026, an estimated $7.21K.
  • Private Wealth Management Group first reported a position in Avidity Biosciences in Q4 2023 and held it in 9 quarters.
  • Private Wealth Management Group's Avidity Biosciences position peaked at $7.21K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Private Wealth Management Group's 13F filing for Q1 2026, filed 23 Apr 2026.